Editorial
Induction chemotherapy for nasopharyngeal carcinoma
BMJ · 15.04.2025 · r652
DOI: 10.1136/bmj.r652 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, online erschienen am 15.04.2025. Verfasst von Man Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.
- Department of Radiation Oncology, Xi'an Gaoxin Hospital, Xi'an, Shaanxi, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Patient author, Shaanxi, China.
- Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China lixuqi@163.com.
Zitieren
APA
Xu, M., Yang, S., Cui, E., Wang, Z., & Li, X. (2025). Induction chemotherapy for nasopharyngeal carcinoma. BMJ, r652. https://doi.org/10.1136/bmj.r652
Vancouver
Xu M, Yang S, Cui E, Wang Z, Li X. Induction chemotherapy for nasopharyngeal carcinoma. BMJ. 2025:r652. doi:10.1136/bmj.r652
BibTeX
@article{Xu2025,
author = {Xu, Man and Yang, Shuting and Cui, Erying and Wang, Zheng and Li, Xuqi},
title = {Induction chemotherapy for nasopharyngeal carcinoma},
journal = {BMJ},
year = {2025},
pages = {r652},
doi = {10.1136/bmj.r652}
}
EUVIMED